New senior VP of cardiovascular therapeutics at Gilead
This article was originally published in Scrip
Dr Seigo Izumo has joined Gilead Sciencesas senior vice-president of cardiovascular therapeutics. Dr Izumo most recently served as vice-president and global head of cardiovascular research at Novartis Institutes for BioMedical Research. Before that, he was professor of medicine at Harvard Medical School and at Harvard-MIT Division of Health Sciences and Technology.